US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 120.380
  • -0.310-0.26%
Close Dec 13 16:00 ET
  • 120.380
  • 0.0000.00%
Post 20:01 ET
28.86BMarket Cap-59.27P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
39.04%1.24B
-23.26%128.7M
-85.31%187.6M
-77.94%3.82B
-65.43%1.48B
-74.13%895.3M
-94.75%167.7M
-79.97%1.28B
-8.78%17.31B
-22.67%4.28B
Operating revenue
39.04%1.24B
-23.26%128.7M
-85.31%187.6M
-77.94%3.82B
-65.43%1.48B
-74.13%895.3M
-94.75%167.7M
-79.97%1.28B
-8.78%17.31B
-22.67%4.28B
Cost of revenue
10.57%178.9M
-63.29%59.8M
-38.44%59.1M
-79.97%599.8M
-2.40%179.1M
-78.51%161.8M
-78.69%162.9M
-92.58%96M
2.87%3B
-68.54%183.5M
Gross profit
45.32%1.07B
1,335.42%68.9M
-89.12%128.5M
-77.51%3.22B
-68.25%1.3B
-72.92%733.5M
-99.80%4.8M
-76.75%1.18B
-10.89%14.32B
-17.27%4.09B
Operating expense
59.81%1.06B
82.20%1.04B
20.72%635.7M
15.07%2.32B
-11.46%559.9M
35.52%660.4M
11.48%568.1M
60.65%526.6M
76.77%2.01B
72.88%632.4M
Selling and administrative expenses
-1.95%150.5M
33.28%183.8M
6.94%132.6M
3.05%557.7M
-1.86%142.3M
2.88%153.5M
-4.57%137.9M
17.98%124M
65.40%541.2M
3.72%145M
-Selling and marketing expense
25.69%18.1M
-28.73%12.9M
27.87%15.6M
5.38%62.7M
23.29%18M
12.50%14.4M
1.69%18.1M
-14.69%12.2M
18.06%59.5M
-18.44%14.6M
-General and administrative expense
-4.82%132.4M
42.65%170.9M
4.65%117M
2.76%495M
-4.68%124.3M
1.98%139.1M
-5.45%119.8M
23.13%111.8M
74.02%481.7M
6.97%130.4M
Research and development costs
10.52%550.3M
56.56%584.6M
51.95%507.5M
16.01%1.78B
13.34%577.8M
45.67%497.9M
-6.56%373.4M
16.86%334M
61.93%1.54B
87.77%509.8M
Other operating expenses
3,840.00%354.6M
369.54%266.7M
-106.41%-4.4M
61.14%-25.8M
-1,246.22%-160.2M
208.43%9M
250.26%56.8M
208.72%68.6M
51.99%-66.4M
73.85%-11.9M
Operating profit
-85.64%10.5M
-71.52%-966.2M
-177.51%-507.2M
-92.65%904.2M
-78.63%740M
-96.71%73.1M
-129.30%-563.3M
-86.23%654.4M
-17.57%12.3B
-24.46%3.46B
Net non-operating interest income expense
-3.95%148.2M
6.15%160.4M
229.08%175.4M
1,081.42%349.7M
-124.52%-9M
4,438.24%154.3M
3,613.95%151.1M
-79.92%53.3M
214.73%29.6M
310.92%36.7M
Non-operating interest income
-0.06%156.2M
10.04%167.7M
118.83%180.1M
637.32%357.6M
-114.43%-5.6M
1,929.87%156.3M
10,060.00%152.4M
-69.75%82.3M
3,133.33%48.5M
12,833.33%38.8M
Non-operating interest expense
300.00%8M
461.54%7.3M
-83.79%4.7M
----
----
-53.49%2M
--1.3M
332.84%29M
----
----
Total other finance cost
----
----
----
-58.20%7.9M
----
----
----
----
-30.77%18.9M
----
Other net income (expense)
-110.92%-67.8M
327.77%620.7M
-320.91%-326.5M
Gain on sale of security
----
----
----
-106.16%-38.4M
----
----
----
----
304.74%623.7M
-306.31%-323.5M
Special income (charges)
----
----
----
-880.00%-29.4M
----
----
----
----
66.67%-3M
----
-Less:Other special charges
----
----
----
880.00%29.4M
----
----
----
----
-66.67%3M
----
Income before tax
-30.21%158.7M
-95.49%-805.8M
-146.88%-331.8M
-90.84%1.19B
-79.10%663.2M
-90.70%227.4M
-117.77%-412.2M
-85.90%707.7M
-13.91%12.95B
-32.70%3.17B
Income tax
-158.98%-39.4M
100.90%2M
-108.13%-16.7M
-92.73%255.8M
-77.03%205.3M
-89.87%66.8M
-134.27%-221.8M
-84.42%205.5M
-25.96%3.52B
-42.24%893.9M
Net income
23.35%198.1M
-324.26%-807.8M
-162.74%-315.1M
-90.14%930.3M
-79.91%457.9M
-91.00%160.6M
-111.39%-190.4M
-86.42%502.2M
-8.34%9.43B
-28.03%2.28B
Net income continuous Operations
23.35%198.1M
-324.26%-807.8M
-162.74%-315.1M
-90.14%930.3M
-79.91%457.9M
-91.00%160.6M
-111.39%-190.4M
-86.42%502.2M
-8.34%9.43B
-28.03%2.28B
Minority interest income
Net income attributable to the parent company
23.35%198.1M
-324.26%-807.8M
-162.74%-315.1M
-90.14%930.3M
-79.91%457.9M
-91.00%160.6M
-111.39%-190.4M
-86.42%502.2M
-8.34%9.43B
-28.03%2.28B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.35%198.1M
-324.26%-807.8M
-162.74%-315.1M
-90.14%930.3M
-79.91%457.9M
-91.00%160.6M
-111.39%-190.4M
-86.42%502.2M
-8.34%9.43B
-28.03%2.28B
Basic earnings per share
22.39%0.82
-325.32%-3.36
-163.29%-1.31
-90.02%3.87
-79.64%1.91
-90.98%0.67
-111.52%-0.79
-86.32%2.07
-8.06%38.78
-27.62%9.38
Diluted earnings per share
22.73%0.81
-325.32%-3.36
-163.90%-1.31
-89.86%3.83
-79.59%1.89
-90.54%0.66
-112.25%-0.79
-85.60%2.05
-4.69%37.77
-23.91%9.26
Dividend per share
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 39.04%1.24B-23.26%128.7M-85.31%187.6M-77.94%3.82B-65.43%1.48B-74.13%895.3M-94.75%167.7M-79.97%1.28B-8.78%17.31B-22.67%4.28B
Operating revenue 39.04%1.24B-23.26%128.7M-85.31%187.6M-77.94%3.82B-65.43%1.48B-74.13%895.3M-94.75%167.7M-79.97%1.28B-8.78%17.31B-22.67%4.28B
Cost of revenue 10.57%178.9M-63.29%59.8M-38.44%59.1M-79.97%599.8M-2.40%179.1M-78.51%161.8M-78.69%162.9M-92.58%96M2.87%3B-68.54%183.5M
Gross profit 45.32%1.07B1,335.42%68.9M-89.12%128.5M-77.51%3.22B-68.25%1.3B-72.92%733.5M-99.80%4.8M-76.75%1.18B-10.89%14.32B-17.27%4.09B
Operating expense 59.81%1.06B82.20%1.04B20.72%635.7M15.07%2.32B-11.46%559.9M35.52%660.4M11.48%568.1M60.65%526.6M76.77%2.01B72.88%632.4M
Selling and administrative expenses -1.95%150.5M33.28%183.8M6.94%132.6M3.05%557.7M-1.86%142.3M2.88%153.5M-4.57%137.9M17.98%124M65.40%541.2M3.72%145M
-Selling and marketing expense 25.69%18.1M-28.73%12.9M27.87%15.6M5.38%62.7M23.29%18M12.50%14.4M1.69%18.1M-14.69%12.2M18.06%59.5M-18.44%14.6M
-General and administrative expense -4.82%132.4M42.65%170.9M4.65%117M2.76%495M-4.68%124.3M1.98%139.1M-5.45%119.8M23.13%111.8M74.02%481.7M6.97%130.4M
Research and development costs 10.52%550.3M56.56%584.6M51.95%507.5M16.01%1.78B13.34%577.8M45.67%497.9M-6.56%373.4M16.86%334M61.93%1.54B87.77%509.8M
Other operating expenses 3,840.00%354.6M369.54%266.7M-106.41%-4.4M61.14%-25.8M-1,246.22%-160.2M208.43%9M250.26%56.8M208.72%68.6M51.99%-66.4M73.85%-11.9M
Operating profit -85.64%10.5M-71.52%-966.2M-177.51%-507.2M-92.65%904.2M-78.63%740M-96.71%73.1M-129.30%-563.3M-86.23%654.4M-17.57%12.3B-24.46%3.46B
Net non-operating interest income expense -3.95%148.2M6.15%160.4M229.08%175.4M1,081.42%349.7M-124.52%-9M4,438.24%154.3M3,613.95%151.1M-79.92%53.3M214.73%29.6M310.92%36.7M
Non-operating interest income -0.06%156.2M10.04%167.7M118.83%180.1M637.32%357.6M-114.43%-5.6M1,929.87%156.3M10,060.00%152.4M-69.75%82.3M3,133.33%48.5M12,833.33%38.8M
Non-operating interest expense 300.00%8M461.54%7.3M-83.79%4.7M---------53.49%2M--1.3M332.84%29M--------
Total other finance cost -------------58.20%7.9M-----------------30.77%18.9M----
Other net income (expense) -110.92%-67.8M327.77%620.7M-320.91%-326.5M
Gain on sale of security -------------106.16%-38.4M----------------304.74%623.7M-306.31%-323.5M
Special income (charges) -------------880.00%-29.4M----------------66.67%-3M----
-Less:Other special charges ------------880.00%29.4M-----------------66.67%3M----
Income before tax -30.21%158.7M-95.49%-805.8M-146.88%-331.8M-90.84%1.19B-79.10%663.2M-90.70%227.4M-117.77%-412.2M-85.90%707.7M-13.91%12.95B-32.70%3.17B
Income tax -158.98%-39.4M100.90%2M-108.13%-16.7M-92.73%255.8M-77.03%205.3M-89.87%66.8M-134.27%-221.8M-84.42%205.5M-25.96%3.52B-42.24%893.9M
Net income 23.35%198.1M-324.26%-807.8M-162.74%-315.1M-90.14%930.3M-79.91%457.9M-91.00%160.6M-111.39%-190.4M-86.42%502.2M-8.34%9.43B-28.03%2.28B
Net income continuous Operations 23.35%198.1M-324.26%-807.8M-162.74%-315.1M-90.14%930.3M-79.91%457.9M-91.00%160.6M-111.39%-190.4M-86.42%502.2M-8.34%9.43B-28.03%2.28B
Minority interest income
Net income attributable to the parent company 23.35%198.1M-324.26%-807.8M-162.74%-315.1M-90.14%930.3M-79.91%457.9M-91.00%160.6M-111.39%-190.4M-86.42%502.2M-8.34%9.43B-28.03%2.28B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.35%198.1M-324.26%-807.8M-162.74%-315.1M-90.14%930.3M-79.91%457.9M-91.00%160.6M-111.39%-190.4M-86.42%502.2M-8.34%9.43B-28.03%2.28B
Basic earnings per share 22.39%0.82-325.32%-3.36-163.29%-1.31-90.02%3.87-79.64%1.91-90.98%0.67-111.52%-0.79-86.32%2.07-8.06%38.78-27.62%9.38
Diluted earnings per share 22.73%0.81-325.32%-3.36-163.90%-1.31-89.86%3.83-79.59%1.89-90.54%0.66-112.25%-0.79-85.60%2.05-4.69%37.77-23.91%9.26
Dividend per share
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Abits
ABTS
+9.91%
Bakkt Holdings
BKKT
+5.92%
Riot Platforms
RIOT
+5.35%
Canaan
CAN
+3.62%
CATHEDRA BITCOIN INC
CBTTF
+1.62%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.04%